Stock Region Penny Picks
Stock Region Penny Picks Daily Watchlist: Wednesday, December 3, 2025
Stock Region Penny Picks Daily Watchlist: Wednesday, December 3, 2025
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: This newsletter is for informational and entertainment purposes only. The content provided is not financial advice. All investments carry risks, and you should always conduct your own research and consult with a professional before making any financial decisions. We may or may not hold positions in the stocks mentioned.
What a wild day yesterday was. Some of these tickers were absolutely flying, and if you blinked, you might have missed it. Let’s break down the news and see what’s cooking for today’s watchlist.
Today’s Top Watchlist
$CAPR - Capricor Therapeutics
This one was the showstopper yesterday. Halted on its way up to close at a massive $35.12, this was a monster move. Why? They announced positive topline results from their pivotal Phase 3 study for a treatment for Duchenne Muscular Dystrophy. This is huge, life-changing news for patients and, consequently, game-changing for the company. This kind of data can send a biotech stock into another stratosphere. Keep a close eye on this one for continuation. The momentum is undeniable.
$IRBT - iRobot Corporation
From near death to a 57% gain in a single day! $IRBT rocketed to $3.07 on insane volume after a report suggested the Trump administration might issue an executive order on robotics. This is purely speculative momentum, driven by a political headline. These moves can be explosive but also incredibly risky. If you’re playing this, be nimble. It’s a trader’s dream but can turn into a nightmare just as fast.
$CLNN - Clene Inc.
Another biotech making serious waves. $CLNN announced statistically significant results for their ALS treatment, supporting an accelerated approval pathway. This is precisely the kind of catalyst that gets Wall Street excited. “Accelerated approval” are the magic words. This news gives the company a clearer path forward and could attract significant investor attention. Definitely one to watch.
$ONDS - Ondas Holdings
From medicine to defense, $ONDS scored a major strategic government tender to develop an autonomous border-protection system using thousands of drones. This is a massive contract and a huge vote of confidence from the government. It’s not just a pilot program; it’s a full-scale deployment. This could mean a steady, long-term revenue stream. The market loves government contracts, so this one is hot.
$AEVA - Aeva Technologies, Inc.
In the auto-tech space, $AEVA secured an exclusive global production contract with a major European passenger OEM. “Exclusive” and “global” are keywords here. This isn’t a small deal; it’s a significant partnership that validates their technology and locks in a major customer. This could be the start of a serious ramp-up in production and revenue.
Other Movers & Shakers
$IMRN - Immuron: Another Department of Defense award. Military contracts are always a good look, and this adds to their credibility.
$TLYS - Tilly’s, Inc.: They reported earnings and beat estimates on both the top and bottom lines. In a tough retail environment, beating expectations is a solid win. This might bring some buyers back into the stock.
$RBOT - Vicarious Surgical: A new Canadian patent for their surgical robotics system. Patents protect their tech and build a moat around their business. Every patent grant strengthens their long-term position.
$SKYX - SKYX Platforms: Launched their new smart home products on their e-commerce site. Direct-to-consumer sales can be a high-margin business, so this is a key step in their growth.
$BTQ - BTQ Technologies: Getting research coverage from a well-known digital asset firm is a big deal for a small company. It adds legitimacy and puts them on the radar of a whole new class of investors.
It was a fantastic day for news flow, creating some incredible opportunities. As always, trade smart, manage your risk, and don’t chase blindly.
Happy trading!
End Disclaimer: The information in this newsletter is not a recommendation to buy or sell any security. The author is not a licensed financial advisor. The author may have a financial interest in the companies mentioned. Please do your own due diligence before making any investment decisions.